Intelligent Dual-Lock Deoxyribonucleic Acid Automatons Boosting Precise Tumor Imaging

ACS Appl Mater Interfaces. 2023 Jan 25;15(3):3826-3838. doi: 10.1021/acsami.2c20024. Epub 2023 Jan 10.

Abstract

An early and accurate cancer diagnosis holds the potential to improve treatment and prognosis. Nevertheless, the complexity of the biological system limits the selectivity of existing approaches and makes tumor imaging in vivo particularly challenging. In this study, tumor-specific fluorescence imaging was achieved by building intelligent dual-lock deoxyribonucleic acid automatons (IDEAs) that employed a DNA walking system standing on ZrMOF@MnO2 multifunctional nanocomposites for controllable molecular recognition. The IDEAs exhibited significantly enhanced fluorescence signals only in the coexistence of both miRNA and GSH of tumor cells, enabling accurate distinguishing of tumor cells from healthy ones. Furthermore, the feasibility and specificity of IDEAs were also validated in vivo with tumor bearing mice successfully. This work highlights the potential of the proposed IDEA strategy for tumor-specific imaging, paving the way for successful precision diagnosis and treatment.

Keywords: DNA automaton; cancer diagnosis; dual lock; fluorescent imaging; specificity.

MeSH terms

  • Animals
  • DNA
  • Manganese Compounds
  • Mice
  • MicroRNAs*
  • Neoplasms* / diagnostic imaging
  • Optical Imaging / methods
  • Oxides

Substances

  • Manganese Compounds
  • Oxides
  • MicroRNAs
  • DNA